30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Chuck Casamento

Track

Insider profile

Currently holds positions in Relmada Therapeutics Inc, Astex Pharmaceuticals Inc and GridAI Technologies Corp

Performance

Overall performance
1.6
Performance over holding periods
4.2
30 days 90 days 120 days
Average return 37% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
4 50% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Performance for realised trades
4.4
Average return -100%
Success rate 73%
Average holding period 220
Transactions 28
Ranking by realised performance

Positions

Position Company Period
Independent Chairman of the Board Relmada Therapeutics Inc June 15, 2017 -
Independent Director Astex Pharmaceuticals Inc Jan. 1, 2007 -
Independent Director GridAI Technologies Corp March 1, 2017 -
Executive Director and Principal, The Sage Group International Stem Cell Corp June 1, 2010 - June 21, 2018
Independent Director Relmada Therapeutics Inc July 14, 2015 - June 15, 2017
Independent Director Vivus Inc April 17, 2008 - July 19, 2013
Chairman of the Board RespireRx Pharmaceuticals Inc Aug. 10, 2012 - March 22, 2013
Independent Director RespireRx Pharmaceuticals Inc July 1, 1997 - Aug. 10, 2012
Chuck Casamento's trades of Relmada Therapeutics Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2024-09-11 2024-09-09
B Purchase
18,160 +39.1%
356.94
US$1,692,888 		18,160 +39.1% 356.94 US$1,692,888
2023-09-18 2023-09-15
S Sale
36,034 -26.9%
345.49
US$3,280,309 		36,034 -26.9% 345.49 US$3,280,309
2023-09-15 2023-09-15
PrS Proposed sale
54,267
147.11
US$1,693,131 		54,267 147.11 US$1,693,131
2023-09-07 2023-08-31
PrS Proposed sale
6,053
0.30
US$1,820 		6,053 0.30 US$1,820
2023-09-05 2023-08-31
S Sale
6,053 -49.8%
0.30
US$1,816 		6,053 -49.8% 0.30 US$1,816
2022-04-05 2022-04-01
PlS Planned sale
3,300 -100.0%
29.00
US$95,700 		3,300 -100.0% 29.00 US$95,700
2022-04-05 2022-04-01
PlS Planned sale
3,300 -50.0%
29.00
US$95,700 		3,300 -50.0% 29.00 US$95,700
2022-04-05 2022-04-01
PlS Planned sale
3,300 -33.3%
29.00
US$95,700 		3,300 -33.3% 29.00 US$95,700
2022-04-05 2022-04-01
PlS Planned sale
3,300 -25.0%
29.00
US$95,700 		3,300 -25.0% 29.00 US$95,700
2022-04-05 2022-04-01
PlS Planned sale
3,300 -20.0%
29.00
US$95,700 		3,300 -20.0% 29.00 US$95,700
2022-04-05 2022-04-01
PlS Planned sale
3,300 -16.7%
29.00
US$95,700 		3,300 -16.7% 29.00 US$95,700
2021-06-02 2021-06-01
PlS Planned sale
2,480 -26.3%
33.19
US$82,300 		2,480 -26.3% 33.19 US$82,300
2021-06-02 2021-06-01
PlS Planned sale
520 -5.2%
34.08
US$17,721 		520 -5.2% 34.08 US$17,721
2021-04-05 2021-04-01
PlS Planned sale
1,691 -11.5%
35.04
US$59,253 		1,691 -11.5% 35.04 US$59,253
2021-04-05 2021-04-01
PlS Planned sale
1,309 -8.2%
35.93
US$47,028 		1,309 -8.2% 35.93 US$47,028
2021-03-02 2021-03-01
PlS Planned sale
3,000 -15.8%
33.87
US$101,618 		3,000 -15.8% 33.87 US$101,618
2021-02-02 2021-02-01
PlS Planned sale
1,663 -8.1%
33.90
US$56,376 		1,663 -8.1% 33.90 US$56,376
2021-02-02 2021-02-01
PlS Planned sale
1,337 -6.1%
33.30
US$44,522 		1,337 -6.1% 33.30 US$44,522
2021-01-05 2021-01-04
PlS Planned sale
3,000 -12.0%
32.11
US$96,342 		3,000 -12.0% 32.11 US$96,342
2020-12-02 2020-12-01
PlS Planned sale
3,000 -10.7%
35.74
US$107,219 		3,000 -10.7% 35.74 US$107,219
2020-11-03 2020-11-02
PlS Planned sale
3,000 -5.8%
30.29
US$90,864 		3,000 -5.8% 30.29 US$90,864
2020-10-02 2020-10-01
PlS Planned sale
3,000 -5.4%
37.99
US$113,956 		3,000 -5.4% 37.99 US$113,956
2020-09-02 2020-09-01
PlS Planned sale
3,000 -5.2%
34.74
US$104,207 		3,000 -5.2% 34.74 US$104,207
2020-08-04 2020-08-03
PlS Planned sale
3,000 -8.1%
35.74
US$107,213 		3,000 -8.1% 35.74 US$107,213
2020-07-02 2020-07-01
PlS Planned sale
3,000 -7.5%
43.89
US$131,677 		3,000 -7.5% 43.89 US$131,677
2019-01-02 2018-12-28
B Purchase
9,000 +18.9%
1.41
US$12,690 		9,000 +18.9% 1.41 US$12,690